Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-04 Sale | 2024-03-04 6:12 pm | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 3,934 | $41.86 | $164,664 | 329,851 (Direct) | View |
| 2023-03-02 Sale | 2023-03-03 4:30 pm | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 1,370 | $31 | $42,465 | 247,068 (Direct) | View |
| 2022-01-12 Sale | 2022-01-14 5:01 pm | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 15,000 | $51.85 | $777,684 | 54,488 (Direct) | View |
| 2021-12-03 Sale | 2021-12-03 6:43 pm | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 10,000 | $53.56 | $535,637 | 207,413 (Direct) | View |
| 2021-09-03 Sale | 2021-09-03 5:57 pm | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 10,000 | $60.12 | $601,180 | 217,155 (Direct) | View |
| 2021-06-03 Sale | 2021-06-04 4:16 pm | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 10,000 | $46.87 | $468,695 | 227,155 (Direct) | View |
| 2021-03-11 Sale | 2021-03-15 9:08 pm | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 10,000 | $60.15 | $601,528 | 476,317 (Direct) | View |
| 2021-03-08 Sale | 2021-03-08 8:01 pm | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 10,000 | $50.65 | $506,470 | 244,061 (Direct) | View |
| 2021-03-03 Sale | 2021-03-05 5:26 pm | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 20,000 | $44.78 | $895,634 | 254,061 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-01 Option Award | 2024-03-04 6:12 pm | N/A 2034-02-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 218,750 | $0 | 329,851 (Direct) | View |
| 2023-06-02 Exercise | 2023-06-02 2:17 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 10,000 | $2.08 | 244,934 (Direct) | View |
| 2023-06-02 Exercise | 2023-06-02 2:17 pm | N/A 2029-08-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 10,000 | $0 | 244,934 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 4:30 pm | N/A 2033-02-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 166,250 | $0 | 247,068 (Direct) | View |
| 2022-10-21 Exercise | 2022-10-24 08:00 am | N/A N/A | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 10,000 | $2.08 | 221,178 (Direct) | View |
| 2022-10-21 Exercise | 2022-10-24 08:00 am | N/A 2029-08-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 10,000 | $0 | 221,178 (Direct) | View |
| 2022-10-17 Exercise | 2022-10-17 8:12 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 10,000 | $2.08 | 221,178 (Direct) | View |
| 2022-10-17 Exercise | 2022-10-17 8:12 pm | N/A 2029-08-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 10,000 | $0 | 221,178 (Direct) | View |
| 2022-05-03 Exercise | 2022-05-03 7:26 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 20,000 | $2.08 | 220,713 (Direct) | View |
| 2022-05-03 Exercise | 2022-05-03 7:26 pm | N/A 2029-08-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 20,000 | $0 | 220,713 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 4:30 pm | N/A 2032-02-29 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 93,300 | $0 | 120,814 (Direct) | View |
| 2022-01-14 Exercise | 2022-01-14 5:15 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 10,000 | $2.08 | 207,413 (Direct) | View |
| 2022-01-14 Exercise | 2022-01-14 5:15 pm | N/A 2029-08-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 10,000 | $0 | 207,413 (Direct) | View |
| 2022-01-12 Exercise | 2022-01-14 5:01 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 15,000 | $2.08 | 54,488 (Direct) | View |
| 2022-01-12 Exercise | 2022-01-14 5:01 pm | N/A 2029-08-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 15,000 | $0 | 54,488 (Direct) | View |
| 2021-12-03 Exercise | 2021-12-03 6:43 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 10,000 | $2.08 | 207,413 (Direct) | View |
| 2021-12-03 Exercise | 2021-12-03 6:43 pm | N/A 2029-08-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 10,000 | $0 | 207,413 (Direct) | View |
| 2021-11-23 Exercise | 2021-11-23 4:59 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 10,000 | $2.08 | 217,155 (Direct) | View |
| 2021-11-23 Exercise | 2021-11-23 4:59 pm | N/A 2029-08-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 10,000 | $0 | 217,155 (Direct) | View |
| 2021-09-03 Exercise | 2021-09-03 5:57 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 10,000 | $2.08 | 217,155 (Direct) | View |
| 2021-09-03 Option Award | 2021-09-03 5:57 pm | N/A 2029-08-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 10,000 | $0 | 217,155 (Direct) | View |
| 2021-06-03 Exercise | 2021-06-04 4:16 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 10,000 | $2.08 | 227,155 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-04 4:16 pm | N/A 2029-08-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 10,000 | $0 | 227,155 (Direct) | View |
| 2021-04-13 Exercise | 2021-04-13 6:37 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 7,000 | $2.08 | 236,899 (Direct) | View |
| 2021-04-13 Exercise | 2021-04-13 6:37 pm | N/A 2029-08-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 7,000 | $0 | 236,899 (Direct) | View |
| 2021-03-11 Exercise | 2021-03-15 9:08 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 10,000 | $2.08 | 476,317 (Direct) | View |
| 2021-03-11 Exercise | 2021-03-15 9:08 pm | N/A 2030-08-19 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 10,000 | $0 | 476,317 (Direct) | View |
| 2021-03-08 Exercise | 2021-03-08 8:01 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 10,000 | $2.08 | 244,061 (Direct) | View |
| 2021-03-08 Exercise | 2021-03-08 8:01 pm | N/A 2030-08-19 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 10,000 | $0 | 244,061 (Direct) | View |
| 2021-03-03 Exercise | 2021-03-05 5:26 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 20,000 | $2.08 | 254,061 (Direct) | View |
| 2021-03-03 Exercise | 2021-03-05 5:26 pm | N/A 2030-08-19 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 20,000 | $0 | 254,061 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 4:27 pm | N/A 2031-02-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 140,000 | $0 | 140,000 (Direct) | View |
| 2020-08-20 Option Award | 2020-08-21 6:21 pm | N/A 2030-08-19 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 32,904 | $0 | 32,904 (Direct) | View |
Ownership | 2020-08-20 8:32 pm | N/A 2029-08-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 0 | $0 | 415,397 (Direct) | View |